HA

Hitesh Anantrai Mehta

Active Director Director DIN 01082799
DIN 01082799 First appointment Sep 1994 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 1994
Shareholding value •••• Premium profile

About Hitesh Anantrai Mehta

Data last updated:

Hitesh Anantrai Mehta is a Director at Anicare Pharmaceuticals Private Limited (since 1994). The company operates in Pharma. Anicare Pharmaceuticals Private Limited reported revenue of ₹13.97 Cr (FY 2025).

DIN 01082799
Primary Designation Director
Industry Pharma
First Appointment 23 Sep 1994
Oldest Company Age 32 yrs
Largest company Anicare Pharmaceuticals Private Limited · ₹13.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Sep 19941994₹13.97 Cr (FY 2025)Active

Board colleagues of Hitesh Anantrai Mehta

Directorship timeline

Open interactive timeline →
Anicare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hitesh Anantrai Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitesh Anantrai Mehta

Hitesh Anantrai Mehta currently holds 1 directorship: Anicare Pharmaceuticals Private Limited (Director, since 23 Sep 1994, revenue ₹13.97 Cr (FY 2025)).

Hitesh Anantrai Mehta was first appointed on 23 Sep 1994 as Director at Anicare Pharmaceuticals Private Limited.

The current boards of Hitesh Anantrai Mehta's companies include Amit Anantrai Mehta (Anicare Pharmaceuticals Private Limited), Manisha Anantrai Mehta (Anicare Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available